Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sunitinib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 CNS 1

Conditions

Glioblastoma 11 Brain Neoplasms 9 Glioma 4 Astrocytoma 4 Oligodendroglioma 3 Meningioma 3 Gliosarcoma 3 Carcinoma, Renal Cell 2 Recurrence 1 Paraganglioma 1 Neurofibromatosis 2 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Hemangioblastoma 1 Familial ependymoma 1 Central Nervous System Neoplasms 1 Central Nervous System Metastases 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Temozolomide 22 Bevacizumab 18 Cyclophosphamide 7 Lomustine 6 Irinotecan 6 Carboplatin 6 3-Iodobenzylguanidine 6 Topotecan 5 Radiotherapy 5 Radiosurgery 4 Nivolumab 4 Filgrastim 4 Everolimus 4 fludarabine phosphate 3 Vincristine 3 Sirolimus 3 IL13-PE38 3 Etoposide 3 Drug Therapy 3 Busulfan 3 Antilymphocyte Serum 3 thymoglobulin 2 sonidegib 2 ribociclib 2 pembrolizumab 2 paclitaxel-Angiopep-2 conjugate 2 olaparib 2 fluorodopa F 18 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00535379 2010-08-30

SURGE01-07

Medical University Innsbruck

Phase 2 Unknown

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡